Evidence map›Paper›PMID 28749477›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Mapping the genomic landscape of inherited retinal disease genes prioritizes genes prone to coding and noncoding copy-number variations.

Kristof Van Schil, Sarah Naessens, Stijn Van de Sompele, Marjolein Carron, Alexander Aslanidis, Caroline Van Cauwenbergh, Anja Kathrin Mayer, Mattias Van Heetvelde, Miriam Bauwens, Hannah Verdin and 11 more

Erratum issuedAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Non-coding single-nucleotide and structural variants affecting the EYS putative promoter cause autosomal recessive retinitis pigmentosa.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Whole genome sequencing forHGG advances · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. The landscape of submicroscopic structural variants at theProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Kristof Van SchilCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Sarah NaessensCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Stijn Van de SompeleCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Marjolein CarronCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Alexander AslanidisLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.
Caroline Van CauwenberghCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Anja Kathrin MayerMolecular Genetics Laboratory, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Mattias Van HeetveldeCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Miriam BauwensCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Hannah VerdinCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Frauke CoppietersCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Michael E GreenbergDepartment of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
Marty G YangDepartment of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
Marcus KarlstetterLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.
Thomas LangmannLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.
Katleen De PreterCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Susanne KohlMolecular Genetics Laboratory, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.
Timothy J CherryDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
Bart P LeroyCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
CNV Study Group
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.

Funding

ELECTRICAL STIMULATION OF IMMEDIATE EARLY GENESR37NS028829 · NINDS · HARVARD MEDICAL SCHOOL · PI GREENBERG, MICHAEL ELDON · 1999 to 2019
$7.4M
NINDS NIH HHS R37 NS028829
6 · The paper itself

Abstract

PurposePart of the hidden genetic variation in heterogeneous genetic conditions such as inherited retinal diseases (IRDs) can be explained by copy-number variations (CNVs). Here, we explored the genomic landscape of IRD genes listed in RetNet to identify and prioritize those genes susceptible to CNV formation.MethodsRetNet genes underwent an assessment of genomic features and of CNV occurrence in the Database of Genomic Variants and literature. CNVs identified in an IRD cohort were characterized using targeted locus amplification (TLA) on extracted genomic DNA.ResultsExhaustive literature mining revealed 1,345 reported CNVs in 81 different IRD genes. Correlation analysis between rankings of genomic features and CNV occurrence demonstrated the strongest correlation between gene size and CNV occurrence of IRD genes. Moreover, we identified and delineated 30 new CNVs in IRD cases, 13 of which are novel and three of which affect noncoding, putative cis-regulatory regions. Finally, the breakpoints of six complex CNVs were determined using TLA in a hypothesis-neutral manner.ConclusionWe propose a ranking of CNV-prone IRD genes and demonstrate the efficacy of TLA for the characterization of CNVs on extracted DNA. Finally, this IRD-oriented CNV study can serve as a paradigm for other genetically heterogeneous Mendelian diseases with hidden genetic variation.

Indexed as

Chromosome MappingDNA Copy Number VariationsGenome, HumanGenomicsOpen Reading FramesRNA, UntranslatedAllelesCadherin Related ProteinsCadherinsDatabases, GeneticEye ProteinsGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansRegulatory Sequences, Nucleic AcidRetinal DiseasesCadherin Related ProteinsCadherinsCDHR15, humanEye ProteinsEYS protein, humanRNA, Untranslated

Identifiers

PMID28749477
PMCPMC5787040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.